Covered recipient · General Payments record
TIFFANY MARUM
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,544.28
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $652.03 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $142.21 | 8 |
| Novo Nordisk AS | $123.08 | 6 |
| AIMMUNE THERAPEUTICS, INC. | $108.71 | 4 |
| ABBVIE INC. | $93.59 | 5 |
| Lilly USA, LLC | $68.53 | 4 |
| Indivior Inc. | $55.18 | 2 |
| Acerta Pharma LLC | $42.07 | 3 |
| Merck Sharp & Dohme Corporation | $18.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.97 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104977835 | CMS |
| ABBVIE INC. | $24.03 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104977837 | CMS |
| ABBVIE INC. | $18.26 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104977839 | CMS |
| ABBVIE INC. | $18.67 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104977841 | CMS |
| ABBVIE INC. | $17.66 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104977843 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $34.04 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147021057 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $37.40 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146961818 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $18.99 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146973929 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $18.28 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147005051 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.62 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104534381 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.32 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104525118 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.13 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105795352 | CMS |
| Indivior Inc. | $27.46 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144533015 | CMS |
| Indivior Inc. | $27.72 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144533017 | CMS |
| Lilly USA, LLC | $18.74 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135457972 | CMS |
| Lilly USA, LLC | $17.51 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135450034 | CMS |
| Lilly USA, LLC | $16.12 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135457970 | CMS |
| Lilly USA, LLC | $16.16 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135479977 | CMS |
| Merck Sharp & Dohme LLC | $18.66 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141776103 | CMS |
| Novo Nordisk Inc | $20.69 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096603047 | CMS |
| Novo Nordisk Inc | $22.39 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096572082 | CMS |
| Novo Nordisk Inc | $13.98 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097122760 | CMS |
| Novo Nordisk Inc | $22.58 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096575807 | CMS |
| Novo Nordisk Inc | $23.59 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097364828 | CMS |
| Novo Nordisk Inc | $19.85 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096875795 | CMS |
| PFIZER INC. | $1.10 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131896913 | CMS |
| PFIZER INC. | $16.12 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131168018 | CMS |
| PFIZER INC. | $19.47 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131168015 | CMS |
| PFIZER INC. | $18.07 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131166729 | CMS |
| PFIZER INC. | $22.03 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131398609 | CMS |
| PFIZER INC. | $19.50 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131520134 | CMS |
| PFIZER INC. | $17.93 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131742960 | CMS |
| PFIZER INC. | $27.99 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131892307 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.